Selumetinib can reduce the pain and size of tumors caused in adults by neurofibromatosis type 1, a rare genetic disease for which there is currently no effective pharmacological treatment.

The study, called KOMET and published in The Lancet, has shown that in 1 in every 5 adults with plexiform neurofibromas treated with selumetinib, there was a significant reduction in the tumor.

Neurofibromatosis Type 1 (NF1) is a genetic disorder characterised by benign tumours and cutaneous lesions, including neurofibromas. This case report describes a boy in his early 10s with NF1 who ...

Learn what a plantar fibroma is, including how it’s diagnosed, when to get treatment, and more.

For ap­prox­i­mate­ly sev­en years, Sherisse Alexan­der, 28, from Tor­tu­ga Vil­lage, Clax­ton Bay, has been liv­ing with Plex­i­form Neu­rofi­bro­ma, a rare and in­cur­able nerve dis­or­der.

AstraZeneca announced that it has entered into a strategic research collaboration with CSPC Pharmaceutical Group to accelerate the discovery and development of novel oral therapies using artificial ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion.

SOME evaluation of the dielectric properties of cotton at various moisture contents was needed because of a project to use thermionic heating on the eighty ovens of the Alexandria Testing House ...

Other features, including cortical tubers, SEN, seizures, retinal phakomas, ungual fibromas, and renal cysts, began to show significance when combining both datasets in the meta-analysis.

Introduction Primary tumors of the heart are rare. Metastatic tumors to, or that are directly invasive into, the heart are far more common. Approximately 75% of primary tumors are benign and 50 ...